NCT03124069View on ClinicalTrials.gov

A Development Study to Evaluate a Nasal Mask for the Treatment of Obstructive Sleep Apnea

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

April 24, 2017

Primary Completion Date

May 26, 2017

Study Completion Date

September 30, 2017

Conditions
Obstructive Sleep Apnea
Interventions
DEVICE

F&P Saturn

Participants will be placed on this arm for a total of 14 ± 5 days from Visit 2. Participants will be using the trial nasal mask during this treatment arm.

Trial Locations (1)

33186

Clinical Trials of Florida, South Miami

All Listed Sponsors
lead

Fisher and Paykel Healthcare

INDUSTRY

NCT03124069 - A Development Study to Evaluate a Nasal Mask for the Treatment of Obstructive Sleep Apnea | Biotech Hunter | Biotech Hunter